YD Bio Limited (NASDAQ:YDES) Stock Short Interest Report for September

Posted by Geri Gentry on Oct 13th, 2026

YD Bio Limited (NASDAQ:YDES – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 177,332 shares, an increase of 312.8% from the September 15th total of 42,960 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 728,505 shares, the days-to-cover ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Wall Street Zen raised YD Bio to a “hold” rating in a research note on Saturday, September 26th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Read Our Latest Analysis on YD Bio

YD Bio Price Performance

YDES stock opened at $6.33 on Tuesday. The firm has a 50 day moving average of $4.35 and a two-hundred day moving average of $4.16. YD Bio has a 12 month low of $1.70 and a 12 month high of $22.00.

YD Bio (NASDAQ:YDES – Get Free Report) last released its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share for the quarter. The business had revenue of $0.42 million for the quarter.

Hedge Funds Weigh In On YD Bio

An institutional investor recently raised its stake in YD Bio stock. Cypress Capital Management LLC WY raised its stake in shares of YD Bio Limited (NASDAQ:YDES – Free Report) by 9.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,690 shares of the biotechnology company’s stock after buying an additional 3,000 shares during the period. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 at the end of the most recent quarter.